Cargando…

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018

BACKGROUND: Pseudomonas aeruginosa is intrinsically resistant to many commonly used antimicrobials, and carbapenems are often required to treat infections. We describe the crude incidence, epidemiology, and molecular characteristics of carbapenem-resistant P. aeruginosa (CRPA) in the EIP catchment a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grass, Julian E, Bulens, Sandra N, Bamberg, Wendy M, Janelle, Sarah J, Schutz, Kyle, Jacob, Jesse T, Bower, Chris W, Blakney, Rebekah, Wilson, Lucy E, Vaeth, Elisabeth, Li, Linda, Lynfield, Ruth, Snippes Vagnone, Paula, Dobbins, Ginette, Phipps, Erin C, Hancock, Emily B, Dumyati, Ghinwa, Tsay, Rebecca, Cassidy, P Maureen, West, Nicole, Kainer, Marion A, Mounsey, Jacquelyn, Stanton, Richard A, McAllister, Gillian A, Campbell, Davina, Lutgring, Joseph D, Karlsson, Maria, Walters, Maroya S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811195/ http://dx.doi.org/10.1093/ofid/ofz360.559

Ejemplares similares

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020
por: Duffy, Nadezhda, et al.
Publicado: (2023)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera — United States, 2014–2017
por: Walters, Maroya S., et al.
Publicado: (2018)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

1408. Population-based Nontuberculous Mycobacteria Surveillance in Four Emerging Infections Program Sites, October 2019–March 2020
por: Jackson, Kelly A, et al.
Publicado: (2021)

2462. Public Health Response to Contain the First Outbreak of New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in Minnesota
por: VonBank, Brittany, et al.
Publicado: (2019)

Psychometric Qualities of the Educational Identity Processes Scale (EIPS)
por: Christiaens, Annabelle H. T., et al.
Publicado: (2022)

Enhancing Medical Governance of Care Within an EIP Service
por: Veldmeijer, Claire, et al.
Publicado: (2023)

606. Identification and Characterization of HMB-2, a Novel Metallo-β-Lactamase in a Pseudomonas aeruginosa Isolate
por: Zhu, Wenming, et al.
Publicado: (2019)

479. Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, New York
por: Hatwar, Trupti, et al.
Publicado: (2018)

Proceedings of the EIP on AHA: A3 Action Group on Frailty
por: Illario, Maddalena, et al.
Publicado: (2016)

EIP on AHA Ontology for adherence: Knowledge representation advanced tools
por: Román-Villarán, E, et al.
Publicado: (2019)

Physical health of patients under EIP - a service evaluation
por: Priya, Anu, et al.
Publicado: (2021)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

1933. Characteristics of Community-Associated Extended-Spectrum β-Lactamase Producing Enterobacterales Infections in Monroe County, NY, 2020-2021
por: Tellerman, Julia, et al.
Publicado: (2023)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

The suppressive cap-binding complex factor 4EIP is required for normal differentiation
por: Terrao, Monica, et al.
Publicado: (2018)

Extended Inflammation Parameters (EIP) as Markers of Immune System Cell Activation in Psoriasis
por: Kowalska-Kępczyńska, Anna, et al.
Publicado: (2021)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

115 Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI)
por: Phipps, Erin C., et al.
Publicado: (2014)

Distinct Origins and Transmission Pathways of bla(KPC) Enterobacterales across Three U.S. States
por: Lapp, Zena, et al.
Publicado: (2023)

1640 Antibiotic Use Patterns in a Population with Long Term Care-Onset C. difficile Infection Developing after Recent Hospitalization
por: Felsen, Christina, et al.
Publicado: (2014)

Improving access to Early Intervention in Psychosis (EIP): the 2-week wait for cancer comes to psychosis
por: Singh, Kirit, et al.
Publicado: (2018)

Hospital-Nursing Home Transfer Patterns and Influence on Nursing Home Clostridium difficile Infection Rates
por: Campbell, Lauren, et al.
Publicado: (2017)

Systematic review of antibiotic stewardship interventions for urinary tract infection management in the ambulatory setting
por: Munsiff, Sonal, et al.
Publicado: (2022)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fc4fbh9cj6soh8hqnfsuuka2o6